Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Casselman

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2019
Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trialGabor G Toth, Bernard De Bruyne, Petr Kala, et al.
European Heart Journal|August 17, 2019
Fractional flow reserve in patients with reduced ejection fractionGiuseppe Di Gioia, Bernard De Bruyne, Mariano Pellicano, et al.
Journal of Clinical Medicine|September 10, 2021
Importance of In-Hospital Prospective Registry and Infectious Endocarditis Heart Team to Monitor and Improve Quality of Care in Patients with Infectious EndocarditisGuy Van Camp, Monika Beles, Martin Penicka, et al.
Heart (British Cardiac Society)|August 17, 2022
Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosisPasquale Paolisso, Emanuele Gallinoro, Marc Vanderheyden, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 7, 2024
Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantationEmanuele Gallinoro, Pasquale Paolisso, Dario Tino Bertolone, et al.
European Journal of Heart Failure|January 22, 2024
Myocardial sodium-glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS studyLucia Scisciola, Pasquale Paolisso, Marta Belmonte, et al.
Heart (British Cardiac Society)|January 4, 2023
Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinicsPasquale Paolisso, Monika Beles, Marta Belmonte, et al.
American Heart Journal|March 21, 2016
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trialMarko Banovic, Bernard Iung, Jozef Bartunek, et al.
Circulation|August 21, 2023
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 TrialFrederik M Zimmermann, Victoria Y Ding, Nico H J Pijls, et al.
Lancet (London, England)|April 2, 2025
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trialWilliam F Fearon, Frederik M Zimmermann, Victoria Y Ding, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2019
Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trialGabor G Toth, Bernard De Bruyne, Petr Kala, et al.
European Heart Journal|August 17, 2019
Fractional flow reserve in patients with reduced ejection fractionGiuseppe Di Gioia, Bernard De Bruyne, Mariano Pellicano, et al.
Journal of Clinical Medicine|September 10, 2021
Importance of In-Hospital Prospective Registry and Infectious Endocarditis Heart Team to Monitor and Improve Quality of Care in Patients with Infectious EndocarditisGuy Van Camp, Monika Beles, Martin Penicka, et al.
Heart (British Cardiac Society)|August 17, 2022
Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosisPasquale Paolisso, Emanuele Gallinoro, Marc Vanderheyden, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 7, 2024
Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantationEmanuele Gallinoro, Pasquale Paolisso, Dario Tino Bertolone, et al.
European Journal of Heart Failure|January 22, 2024
Myocardial sodium-glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS studyLucia Scisciola, Pasquale Paolisso, Marta Belmonte, et al.
Heart (British Cardiac Society)|January 4, 2023
Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinicsPasquale Paolisso, Monika Beles, Marta Belmonte, et al.
American Heart Journal|March 21, 2016
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trialMarko Banovic, Bernard Iung, Jozef Bartunek, et al.
Circulation|August 21, 2023
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 TrialFrederik M Zimmermann, Victoria Y Ding, Nico H J Pijls, et al.
Lancet (London, England)|April 2, 2025
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trialWilliam F Fearon, Frederik M Zimmermann, Victoria Y Ding, et al.
Pageof 7